- A narrative review on adverse effects of dasatinib with a focus on pharmacotherapy of dasatinib-induced pulmonary toxicities
-
Nekoukar Z, Moghimi M, Salehifar E
- KMID: 2524073
- Blood Res.
- 2021 Dec;56(4):229-242.
- doi: 10.5045/br.2021.2021117
Chronic myeloid leukemia (CML), a myeloproliferative disorder caused by the over activity of BCR-ABL1 (breakpoint cluster region-Abelson), has been successfully treated by Tyrosine kinase inhibitors (TKIs). While imatinib is known... -
- CITED
-
- Close
- SHARE
-
- Close
